PharmAnalysis Group is Other Healthcare Technology Systems in United States that focus on reimbursement research business. They cover business area such as provider, reimbursement planning, biotechnology, medical device, diagnostic, industry, reimbursement and economic assessment, qualitative pricing, reimbursement research, analysis, marketing support, communication, program development, pharmaceutical.
Other Healthcare Technology Systems
-
Reimbursement Research
-
2700 South Quincy Street
Suite 230
Arlington, VA 22206
United States
Private
providerreimbursement planningbiotechnologymedical devicediagnosticindustryreimbursement and economic assessmentqualitative pricingreimbursement researchanalysismarketing supportcommunicationprogram developmentpharmaceutical
* We use standard office opening hours in near PharmAnalysis Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PharmAnalysis Group is Other Healthcare Technology Systems business from United States that founded in - ( years old in ), PharmAnalysis Group business is focusing on Reimbursement Research.
PharmAnalysis Group headquarter office and corporate office address is located in 2700 South Quincy Street Suite 230 Arlington, VA 22206 United States.
PharmAnalysis Group was founded in United States.
In , PharmAnalysis Group is currently focus on reimbursement research sector.
Above is snippet of Google Trends for "reimbursement research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PharmAnalysis Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
